Human Clinical Trials

The High Desert Heart Institute

The High Desert Heart Institute (HDHI) provides stellar primary care and heart disease services to its high-risk patient base.

The HDHI has conducted the most comprehensive human clinical trial ever conducted on a nutritional supplement that reveals profound data that supports the efficacy and the profound health benefits of ProArgi-9+.

This study was fully funded, administered, and directed by the High Desert Heart Institute.

The statistical data that supports the findings of this clinical evaluation will soon be published and available for public review.

To listen to the actual scientific findings of the High Desert Heart Institute click play on the audio player.

Leicester Medical School

The Leicester Medical School, one of the most prestigious Medical Schools in Europe, located in central England, is preparing to conduct a 90-Day, multiple-modality double-blind independent clinical study on the efficacy and quantified human benefits of usage of ProArgi-9+. This test will include Central Aortic Systolic Pressure (CASP) screenings that support the clinical evaluation.

This clinical study will be administered by Dr. Bryan Williams, arguably the number one Cardiologist in Europe, and is being funded by the British Heart Foundation, Britain’s equivalent to the American Heart Association.

As the data from this study is made available, we will publish it on this website.

The High Desert Heart Institute

Victorville, California USA

Clinical Trial Overview

• Based On Nobel Prize-Winning Science

• Usage of ProArgi-9+ formula as

• integrative arginine

• 33 High Risk Test Patients

• Commencement date of Clinical Study is Feb 2nd 2009

Protocol

• Patients under direction of HDHI Physicians

• Each patient receives 20 grams am and 20 grams pm

• 30/60/90 day period data review on patients

Disease Category Subsets

• PVD (Peripheral Vascular Disease)

• Angina

• Malignant Hypertension

• Diabetes Mellitus

• Pulmonary Arterial Hypertension

• Erectile Dysfunction

 

Labs To Determine Baseline 30/60/90 Day Testing

• CMP (Complete Metabolic Panel)

• CBC (Complete Blood Count)

• HgbA1c Hemoglobin 90 day test

• Full Lipid Panel

• Vitamin D3 levels

• Microalbumin

• LFT (Liver Function Test)

• BNP (B-Naturetic Peptide Levels)

• CRP (C-Reactive Protein)

Further Diagnostic Tests

• Echocardiogram

• CardioDynamic Analysis (BioZ)

• 6 Minute Walk Test

• Coronary Calcium Score:
(Computerized tomography)

• Coronary CT Angio IV Contrast

• Ankle - Brachial Index

• Cardio Pulsewave Analysis (B-Pro)

• Doppler Echo

• Blood Oxygen Saturation Levels
(APRIA Health)

Results

The High Desert Heart Institute Human Clinical Study

• 18% increase in HDL cholesterol

• 40% decrease in triglycerides

• 8% glucose reduction

• 25% decrease in C-Reactive proteins

• 11% reduction in creatine levels

• 35% increase in magnesium levels (even though there is no magnesium in the product.)

• Vitamin D levels increased by hundred and 83%

• Systolic Blood Pressure decreased by 13%

• Diastolic Blood Pressure decreased by 17%

• Peripheral blood flow to the feet increased by 16%